Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: The association between maximal muscle strength, disease severity and psychopharmacotherapy among young to middle-aged inpatients with affective disorders – a prospective pilot study

Fig. 3

The development of maximal muscle strength and disease severity over the study course. A: Percentual distribution of the relative total muscle strength (rTFmax) comprising lower extremities (LE), upper extremities (UE), back and abdomen (abd), at time point 1 (t1, N = 70). B: Summary graphs of rTFmax (light grey) and the MADRS (white) scores over the study course (N = 50, p = < 0.001 after Tukey and Bonferroni correction, Friedman test (rTFmax), repeated measures ANOVA (MADRS)). Horizontal lines in boxplots represent median, dotted horizontal lines represent mean; boxes 25th and 75th quartiles; whiskers 5th and 95th percentiles; scatter plots show individual data points. Asterisks indicate significance level (*p < .05, **p < .01, ***p < .001)

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us